Neoplasms
|
0.020 |
Biomarker
|
group |
BEFREE |
After that, the inhibitory role of TRIM45 in the development of tumor was gradually unveiled.
|
31663468 |
2020 |
Neoplasms
|
0.020 |
Biomarker
|
group |
BEFREE |
These findings suggest that TRIM45 is a novel tumor suppressor that stabilizes and activates p53 in glioma.
|
28542145 |
2017 |
Non-Small Cell Lung Carcinoma
|
0.010 |
AlteredExpression
|
disease |
BEFREE |
In this study, we found that TRIM45 was up-regulated in early-stage human non-small-cell lung cancer (NSCLC) tissues.
|
31663468 |
2020 |
Malignant neoplasm of lung
|
0.010 |
AlteredExpression
|
disease |
BEFREE |
High-level expression of TRIM45 in lung cancer tissue may promote cell apoptosis by activating p38 signal and inhibit proliferation by down-regulating p-ERK, which provides a new clue for understanding the tumorigenesis of lung cancer.
|
31663468 |
2020 |
Carcinogenesis
|
0.010 |
AlteredExpression
|
phenotype |
BEFREE |
High-level expression of TRIM45 in lung cancer tissue may promote cell apoptosis by activating p38 signal and inhibit proliferation by down-regulating p-ERK, which provides a new clue for understanding the tumorigenesis of lung cancer.
|
31663468 |
2020 |
Carcinoma of lung
|
0.010 |
AlteredExpression
|
disease |
BEFREE |
High-level expression of TRIM45 in lung cancer tissue may promote cell apoptosis by activating p38 signal and inhibit proliferation by down-regulating p-ERK, which provides a new clue for understanding the tumorigenesis of lung cancer.
|
31663468 |
2020 |
Primary malignant neoplasm of lung
|
0.010 |
AlteredExpression
|
disease |
BEFREE |
High-level expression of TRIM45 in lung cancer tissue may promote cell apoptosis by activating p38 signal and inhibit proliferation by down-regulating p-ERK, which provides a new clue for understanding the tumorigenesis of lung cancer.
|
31663468 |
2020 |
Malignant Neoplasms
|
0.010 |
Biomarker
|
group |
BEFREE |
However, little is known regarding the role of TRIM45 in cancer biology, especially in human glioma.
|
28542145 |
2017 |
Glioblastoma
|
0.010 |
Biomarker
|
disease |
BEFREE |
In addition, CRISPR/Cas9-mediated knockout of TRIM45 promotes proliferation and inhibits apoptosis in glioblastoma cells.
|
28542145 |
2017 |
Glioma
|
0.010 |
Biomarker
|
disease |
BEFREE |
These findings suggest that TRIM45 is a novel tumor suppressor that stabilizes and activates p53 in glioma.
|
28542145 |
2017 |
Adult Glioblastoma
|
0.010 |
Biomarker
|
disease |
BEFREE |
In addition, CRISPR/Cas9-mediated knockout of TRIM45 promotes proliferation and inhibits apoptosis in glioblastoma cells.
|
28542145 |
2017 |
Childhood Glioblastoma
|
0.010 |
Biomarker
|
disease |
BEFREE |
In addition, CRISPR/Cas9-mediated knockout of TRIM45 promotes proliferation and inhibits apoptosis in glioblastoma cells.
|
28542145 |
2017 |
Primary malignant neoplasm
|
0.010 |
Biomarker
|
group |
BEFREE |
However, little is known regarding the role of TRIM45 in cancer biology, especially in human glioma.
|
28542145 |
2017 |
Glioblastoma Multiforme
|
0.010 |
Biomarker
|
disease |
BEFREE |
In addition, CRISPR/Cas9-mediated knockout of TRIM45 promotes proliferation and inhibits apoptosis in glioblastoma cells.
|
28542145 |
2017 |